首页> 外国专利> CRITERION DETERMINATION FOR MEDICAL THERAPY AND EFFECTIVENESS CONTROL OF MEDICAL THERAPY FOR PATIENTS WITH PAINLESS MYOCARDIAL ISCHEMIA

CRITERION DETERMINATION FOR MEDICAL THERAPY AND EFFECTIVENESS CONTROL OF MEDICAL THERAPY FOR PATIENTS WITH PAINLESS MYOCARDIAL ISCHEMIA

机译:无痛性心肌缺血患者的药物治疗标准确定和药物治疗的有效控制

摘要

FIELD: medicine.;SUBSTANCE: invention relates to the medicine, in particular to the cardiology. The ratio of the vegetal hemodynamic equilibration (RVHE) is calculated by the following formula: RVHE = LF: CMCM , where LF is a rate within the range of low frequency which reflects the level of sympatic activity of VNS, CMCH is a coefficient of myocardial central hemodynamic. Medicinal treatment criterion (MTC) is calculated by the following formula: MTC = RVHE * QTd/ IMMLG where RVHE is a vegetal hemodynamic equilibration ratio, QTd is a dispersion of QT interval, and MILVM is a mass index of left ventricular myocardium. Providing the MTC index in the range from 11.58 ± 0.17 till 15.59±0.21, the medical treatment is considered to be justified. In this context the treatment is considered effective the value of medical treatment is in the range of specified interval in the period of three months. The invention expands the arsenal of means to determine the effectiveness of medical therapy for patients with painless myocardial ischemia.;EFFECT: increasing the means to determine the effectiveness of medical therapy for patients with painless myocardial ischemia.;2 ex
机译:药物技术领域本发明涉及药物,尤其涉及心脏病学。通过以下公式计算植物血液动力学平衡的比率(RVHE):RVHE = LF:CMCM,其中LF是反映VNS交感活性水平的低频范围内的比率,CMCH是心肌的系数中心血流动力学。药物治疗标准(MTC)由以下公式计算:MTC = RVHE * QT d / IMMLG其中RVHE是植物血液动力学平衡比,QT d 是QT间隔,MILVM是左心室心肌的质量指数。提供的MTC指数范围为11.58及以上; 0.17至15.59±0.21之间,认为治疗是合理的。在这种情况下,该治疗被认为是有效的,药物治疗的价值在三个月内的指定间隔范围内。本发明扩展了确定无痛性心肌缺血患者的药物治疗效果的手段的范围;效果:增加了无痛性心肌缺血患者的药物治疗效果的确定方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号